Basal Energetics and Phosphocreatine Recovery Kinetics in Ambulatory Boys With Duchenne Muscular Dystrophy
NMR in Biomedicine · 2026-08 · 39 (8)
DOI: 10.1002/nbm.70336 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 21.06.2026. Verfasst von Pratiksha P Awale und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Phosphocreatine, Muscular Dystrophy, Duchenne, Energy Metabolism. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant, NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Duchenne muscular dystrophy (DMD) is an X‐linked recessive condition that is characterized by muscle deterioration, loss of functional abilities, and shortened lifespan. There is growing evidence of skeletal muscle mitochondrial impairments in DMD, and 31 phosphorous magnetic resonance spectroscopy ( 31 P‐MRS) provides a noninvasive marker of functional oxidative capacity of muscle. Therefore, the purpose of this study was to examine 31 P‐MRS indices of energetic status and oxidative capacity in DMD and correlate with clinical functional measures. In this study, we evaluated ambulatory participants with DMD ( n = 21, 8.7 ± 1.9 years) and unaffected age‐matched controls ( n = 20, 9.0 ± 2.8 years) using a 3T MR system. 31 P‐MRS was used to measure relative changes in high‐energy phosphates and muscle pH of the anterior compartment of the lower leg during and following isometric dorsiflexion muscle contractions (120 s rest, 60 s of contractions at 0.5 Hz, and 420 s recovery). Data were analyzed with jMRUI (v7.0), and a mono‐exponential model was used to estimate the time constant (tau) of PCr recovery (PCrτ). We observed that relative concentrations of inorganic phosphate to phosphocreatine (Pi/PCr) and phosphodiesters to ATP (PDE/ATP) were elevated ( p < 0.05) in DMD compared to controls, and the PCrτ recovery was slower ( p < 0.01) in DMD than controls. PCrτ recovery was correlated with the distance covered in the 6‐min walk test (6MWT) ( ρ = −0.61, p < 0.01) and other timed functional measures ( ρ = 0.54–0.67, p < 0.05). The findings from this study demonstrated that energetic status is altered and PCr recovery time is impaired in ambulatory boys with DMD indicating reduced oxidative capacity compared to unaffected controls. Overall, these findings support the use of 31 P‐MRS as a valuable noninvasive tool to evaluate skeletal muscle energetics and mitochondrial function in individuals with DMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Therapy, University of Florida, Gainesville, Florida, USA.
- Department of Physiology and Aging, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Sean C Forbes
Förderung
- Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Awale, P. P., Lopez, C., Taivassalo, T., Vandenborne, K., Walter, G. A., & Forbes, S. C. (2026). Basal Energetics and Phosphocreatine Recovery Kinetics in Ambulatory Boys With Duchenne Muscular Dystrophy. NMR in Biomedicine, 39(8). https://doi.org/10.1002/nbm.70336
Vancouver
Awale PP, Lopez C, Taivassalo T, Vandenborne K, Walter GA, Forbes SC. Basal Energetics and Phosphocreatine Recovery Kinetics in Ambulatory Boys With Duchenne Muscular Dystrophy. NMR in Biomedicine. 2026;39(8). doi:10.1002/nbm.70336
BibTeX
@article{Awale2026,
author = {Awale, Pratiksha P and Lopez, Christophor and Taivassalo, Tanja and Vandenborne, Krista and Walter, Glenn A and Forbes, Sean C},
title = {Basal Energetics and Phosphocreatine Recovery Kinetics in Ambulatory Boys With Duchenne Muscular Dystrophy},
journal = {NMR in Biomedicine},
year = {2026},
volume = {39},
number = {8},
doi = {10.1002/nbm.70336}
}
EUVIMED